Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015-2020.
Oliver Van OekelenNicole BirrerWilliam WessonVincent L GalateEdward Robert Scheffer CliffAaron M GoodmanAl-Ola AbdallahRajshekhar ChakrabortyVinay PrasadGhulam Rehman MohyuddinPublished in: Blood cancer journal (2022)